Bayer and Boston hospitals collaborate on COPD lab

Bayer and two Boston hospitals have joined forces in a chronic lung disease research product, with the trio championing the ‘joint lab’ model as a blueprint for pharmaceutical research.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Americas

Court delivers split ruling in lung drug dispute

1 September 2022 Lengthy opinion invalidated plaintiff’s patent but ruled that defendant’s would still infringe | Patents at issue related to treatment for high blood pressure in the lungs.

Generics

EPO upholds Bayer's Xarelto dosage patents

4 November 2021 Following two-day oral proceedings at the Munich Board of Appeal of the European Patent Office, the court has upheld the validity of a Bayer Pharmaceuticals’ dosing patent for Xarelto.

Big Pharma

Bayer sues over syringes used in CT scans

23 February 2021 Bayer Healthcare is suing medical devices manufacturer Ecomed Solutions over allegedly patent-infringing syringes.